Stockhub

Glenmark Pharmaceuticals Limited: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

20 September 2022

  • curprev 19:3519:35, 20 September 2022 >Nick 1,800 bytes +1,800 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Glenmark Pharmaceuticals Limited, together with its subsidiaries, develops, manufactures, and markets pharmaceutical products in India, North America, Latin America, Europe, Japan, and internationally. The company provides branded and generic formulations in the therapeutic areas of dermatology, respiratory, and oncology; and various active pharmaceutical ingredients. Its product pipeline includes GBR 310, a biosimilar cand..."
Retrieved from "https://stockhub.co/research/Glenmark_Pharmaceuticals_Limited"